FDA
approval
· 2025-07-29
FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)
Summary
FDA approved a supplemental application for buprenorphine hydrochloride from Par Health USA, LLC, indicating approval of a generic product under an ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)